The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study to evaluate penpulimab combined with anlotinib and epirubicin in the first-line treatment of soft tissue sarcoma: Updated.
 
Yuhong Zhou
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Meiyu Fang
No Relationships to Disclose
 
Rongyuan Zhuang
No Relationships to Disclose
 
Yi Feng
No Relationships to Disclose
 
Xi Guo
No Relationships to Disclose
 
Yang You
No Relationships to Disclose
 
Chenlu Zhang
No Relationships to Disclose
 
Zhengqing Song
No Relationships to Disclose
 
Yuqin Ding
No Relationships to Disclose
 
Zhiming Wang
No Relationships to Disclose
 
Rongkui Luo
No Relationships to Disclose
 
Zhengfu Fan
No Relationships to Disclose
 
Hanxing Tong
No Relationships to Disclose
 
Yong Zhang
No Relationships to Disclose
 
Weiqi Lu
No Relationships to Disclose